Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis.

McDougal KE, Fallin MD, Moller DR, Song Z, Cutler DJ, Steiner LL, Cutting GR; ACCESS Research Group.

J Invest Dermatol. 2009 Aug;129(8):1921-6. doi: 10.1038/jid.2008.456. Epub 2009 Feb 19.

2.

Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum.

Labunski S, Posern G, Ludwig S, Kundt G, Bröcker EB, Kunz M.

Acta Derm Venereol. 2001 Jan-Feb;81(1):18-21.

3.

Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren's syndrome.

Karakaya B, van Moorsel CH, van der Helm-van Mil AH, Huizinga TW, Ruven HJ, van der Vis JJ, Grutters JC.

Cytokine. 2014 Oct;69(2):272-6. doi: 10.1016/j.cyto.2014.05.020. Epub 2014 Jun 17.

PMID:
24951298
4.

Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis.

Mrazek F, Holla LI, Hutyrova B, Znojil V, Vasku A, Kolek V, Welsh KI, Vacha J, du Bois RM, Petrek M.

Tissue Antigens. 2005 Feb;65(2):163-71.

PMID:
15713215
5.

Association of six well-characterized polymorphisms in TNF-α and TNF-β genes with sarcoidosis: a meta-analysis.

Feng Y, Zhou J, Gu C, Ding Y, Wan H, Ni L, Niu W.

PLoS One. 2013 Nov 7;8(11):e80150. doi: 10.1371/journal.pone.0080150. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/679667f2-b4aa-42e8-8c59-511f60256420.

6.

TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis.

Pandey JP, Frederick M; ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis.

Hum Immunol. 2002 Jun;63(6):485-91.

PMID:
12039524
7.

Tumor necrosis factor alpha gene polymorphism in serbian patients with sarcoidosis.

Petković TR, Pejcić T, Videnović-Ivanov J, Stoimenov TJ, Janković I, Borovac DN, Radojković D.

Srp Arh Celok Lek. 2013 Mar-Apr;141(3-4):169-72.

8.

Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples.

Bolstad AI, Le Hellard S, Kristjansdottir G, Vasaitis L, Kvarnström M, Sjöwall C, Johnsen SJ, Eriksson P, Omdal R, Brun JG, Wahren-Herlenius M, Theander E, Syvänen AC, Rönnblom L, Nordmark G, Jonsson R.

Ann Rheum Dis. 2012 Jun;71(6):981-8. doi: 10.1136/annrheumdis-2011-200446. Epub 2012 Jan 30.

PMID:
22294627
9.

Associations between TNF-α -308 A/G and lymphotoxin-α +252 A/G polymorphisms and susceptibility to sarcoidosis: a meta-analysis.

Song GG, Kim JH, Lee YH.

Mol Biol Rep. 2014 Jan;41(1):259-67. doi: 10.1007/s11033-013-2859-x. Epub 2013 Nov 7.

PMID:
24197700
10.

E-selectin polymorphism in erythema nodosum secondary to sarcoidosis.

Amoli MM, Llorca J, Gomez-Gigirey A, Garcia-Porrua C, Lueiro M, El-Magadmi M, Fernandez ML, Ollier WE, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2004 Mar-Apr;22(2):230-2.

PMID:
15083893
11.

Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum.

Amoli MM, Donn RP, Thomson W, Hajeer AH, Garcia-Porrua C, Lueiro M, Ollier WE, Gonzalez-Gay MA.

J Rheumatol. 2002 Aug;29(8):1671-3.

PMID:
12180727
12.
13.

Clinical characteristics of patients in a case control study of sarcoidosis.

Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R; Case Control Etiologic Study of Sarcoidosis (ACCESS) research group.

Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1885-9.

PMID:
11734441
14.

Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample.

Zhao ZZ, Nyholt DR, Le L, Thomas S, Engwerda C, Randall L, Treloar SA, Montgomery GW.

Hum Reprod. 2007 Sep;22(9):2389-97. Epub 2007 Jun 26.

PMID:
17595314
15.

Haplotype analysis of a 100 kb region spanning TNF-LTA identifies a polymorphism in the LTA promoter region that is associated with atopic asthma susceptibility in Japan.

Migita O, Noguchi E, Koga M, Jian Z, Shibasaki M, Migita T, Ito S, Ichikawa K, Matsui A, Arinami T.

Clin Exp Allergy. 2005 Jun;35(6):790-6.

PMID:
15969671
16.

Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis.

Takashige N, Naruse TK, Matsumori A, Hara M, Nagai S, Morimoto S, Hiramitsu S, Sasayama S, Inoko H.

Tissue Antigens. 1999 Aug;54(2):191-3.

PMID:
10488747
17.

Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians.

Sharma S, Ghosh B, Sharma SK.

Clin Exp Immunol. 2008 Feb;151(2):251-9. Epub 2007 Dec 6. Review.

18.

TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis.

Kieszko R, Krawczyk P, Chocholska S, Dmoszyńska A, Milanowski J.

Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):131-7.

PMID:
21319595
19.

Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.

Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3161-9. doi: 10.1158/1055-9965.EPI-08-0536.

20.

Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata.

Redler S, Albert F, Brockschmidt FF, Herold C, Hanneken S, Eigelshoven S, Giehl KA, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M, Becker T, Nöthen MM, Betz RC.

Br J Dermatol. 2012 Dec;167(6):1360-5. doi: 10.1111/bjd.12004. Epub 2012 Nov 20.

PMID:
22897480

Supplemental Content

Support Center